INTRODUCTION
Safe water to drink and air to breath are essential for human life. A critical aspect of air and water safety is the absence of pathogenic microorganisms; however the closed nature of spacecraft environments makes control of microbial contaminants all the more critical and difficult. This need is compounded by the attenuation of human immune system function due to long term exposure to microgravity [1] . To achieve control of microorganisms in spacecraft, NASA must develop environmental sensors capable of monitoring the microbial content of recycled air and water. Traditionally, analysis of environmental samples for microbial pathogens relied on culturing the organisms on suitable growth media or propagation of viruses in tissue culture cells. Such methods are costly, slow in that some species of bacteria may take as long as 2 weeks to culture, and in many cases ineffective. Perhaps 99% of all organisms in environmental samples may not be culturable [2] . Although the current plan for monitoring microbial contamination on ISS will utilize culture methods, new technologies for microbial detection are under development that could let astronauts know in hours instead of 1-14 days if there are dangerous pathogens in their air or water. We are developing a new generation of microbial assaYs that rely not on the enumeration of whole bacteria or viruses, but on detection of specific biological macromolecules, such as DNA or RNA, that are unique to each organism to be detected. These assays are based on a technique called the polymerase chain reaction, or PCR.
We are in the early stages of constructing a series of quantitative PCR assays for microorganisms that a biosensor aboard the ISS should be capable of detecting (Table 1) . These assays employ a fluorescent detection chemistry developed at Roche Molecular Systems and Perkin-Elmer/Apptied Biosystems ABI) called the 5' nuclease assay (TaqMan TM PCR) [3] , and instrumentation developed at ABI. The chemistry and instrumentation in concert are capable of determining the number of copies of a gene target that are present in a sample.
Assay development takes place in a commercially available instrument, the ABI Prism ®7700 Sequence Detection System (ABI 7700) [4] . Once conditions are developed for 50 p.I reactions on the ABI 7700, we will test the same assay on a prototypic micro-PCR instrument that is more characteristic of a system which could be deployed on the ISS. PCR -DNA, or deoxyribonucleic acid, is a set of molecular instructions every organism uses to reproduce itself and its component pads. In cells, DNA is found as two long linear strands of polymerized building blocks called nucleotides. These nucleotides come in only four an internal probe labeled with a fluorescent reporter dye (FAM _'er,= 518 nm) and a'quencher dye (TAMRA _'em= 582 nm) [10] . For the intact probe, TAMRA quenches the fluorescent emission of FAM due to their spatial proximity on the probe. During PCR, the probe anneals to the target if the sequence is present, and is cleaved during extension by Taq polymerase.
The resulting separation of reporter and quencher dyes reduces the quenching of FAM by TAMRA. The subsequent increase in FAM fluorescence is a direct consequence of target amplification, whereas the fluorescence from TAMRA, the quencher dye, remains constant irrespective of amplification. The latter point indicates that the emission from the quencher dye can be used as a normalization factor.
Because changes in FAM fluorescence are a function of amplicon accumulation, which is a function of the original PCR template concentration, the 5' nuclease assay is an inherently quantitative technique. However post run quantitative analysis of 5' nuclease assay PCRs could be inaccurate. Although amplicon accumulation during the early cycles of a PCR is exponential, as the amplicon concentration reaches 10 nM that exponential accumulation ends. Because PCR product accumulation kinetics are not constant, accurate quantitation of the number of PCR templates initially in the reaction over a 
Universal bacterial 5' nuclease assay PCROne of the assays the microbial monitor must perform is to measure the total bacterial load of a sample. Because the ribosomal RNA genes in all bacterial species have diverged very little during bacterial evolution, it is possible to design PCR primers and 5' nuclease assay probes that can detect any known species of bacteria [15, 16] 
We were uncertain whether the contaminating DNA in the Taq DNA polymerase we used was at a level where it would compromise the assay sensitivity needed for use on the ISS. To estimate the contaminating DNA concentration we performed PCRs using primers and a 5' nuclease assay probe designed to amplify a segment of the 16S rRNA gene from any bacteria. We did not use bacterial genomic DNA as a PCR template in this reaction. Determination of the number of living bacteria (colony forming units or cfu) in a sample is easily done; however genomic DNA from non-viable bacteria is usually an effective PCR target, and it is difficult to determine the number of non-viable microorganisms in a sample. Instead, because its concentration could be measured much more precisely, we constructed recombinant DNA PCR target for use in this experiment. This small circular molecule of recombinant DNA (=5000 base pairs), called a plasmid, contained a segment of the 16S rRNA gene from the bacteria Ureaplasma urealyticum.
PCRs were performed on a series of plasmid template dilutions (Fig. 4) . In PCRs containing between 10 s and 109 recombinant plasmid molecules the relationship of template concentration to threshold cycle was linear; however all template concentrations below 10 s molecules had approximately the same threshold cycle, around 32. Thus, because of the contaminating bacterial DNA in Taq DNA polymerases, the threshold of detection in a universal bacterial assay (or in an assay for coliform bacteria) can be as high as 10 s templates.
The low sensitivity of the universal bacterial PCR assay is a problem that must be resolved. There is a special preparation of Taq DNA polymerase that contains very low concentrations of bacterial DNA (AmpliTaq TM DNA Polymerase LD, PE Applied Biosystems); however even use of this reagent may not permit the assay sensitivity required for the ISS. Also, as described later, a variation of PCR that uses a template composed of RNA instead of DNA requires a different kind of polymerase for which low DNA versions are not available. Fortunately there are techniques to remove contaminating DNA from DNA polymerases. Methods that have been successful in other PCR applications Although on the ISS there will be no need for a microbial monitor to discriminate between Giardia and Cryptosporidium species that are human pathogens and those that are not, we have designed our PCR assays for these parasites so that they could have terrestrial as well as ISS uses. To achieve this primer pairs have been developed for species-specific PCR detection of G. lamblia and C. parvum. log (initial template concentration in molecules) Figure 6 . MSFC water does not inhibit PCR. A standard curve relating threshold cycles to initial template concentrations is shown. A Sa/mone//a control DNA template diluted over 9 orders of magnitude (from 109 to 10 copies) was detected using the Salmonella PCR Amplification and Detection System when 10 percent of the reaction volume (50 I_1) contained either control water or MSFC water.
the direct quantitation of signal from a fluorescent dye labeled probe [29] . In the micro-PCR instrument a Peltier junction heating/cooling system cycles the reaction containers (microstructures) and is controlled by a microprocessor.
Miniaturization of the PCR sample container is made possible by the use of modern microfabrication techniques. This has drastically reduced the amount of power required to cycle and read the sample. As the thermal cycler gets smaller it is simpler to maintain temperature uniformity and requires much less power to cycle. The instrument consists of a 75 Watt tungsten bulb for illumination and a thermo-electrically cooled CCD camera and a 5-color filter wheel for detection.
Images (1:1) of the 14 mm x 14 mm microstructures are taken at several wavelengths at the end of each thermocycle.
This allows the micro-PCR system to monitor the increase of the reporter fluorescence following PCR. Instead of using the 200 ILl polypropylene tubes used with the 7700. The micro-PCR instrument uses either of two kinds of microstructured reaction containers; one made of polycarbonate and the other from silicon.
The silicon glass microstructures (EG & G IC Sensors; Milpitas CA) used to run PCR were designed to be 14 x 14 mm for compatibility with the CCD imaging system employed (Fig. 7A) . Each contained an array of wells equipped with a fill hole for manual addition of PCR sample and reagent, and a vent hole to allow air to escape during filling. A 0.70 mm thick silicon wafer was anisotropically etched to yield 0.5 mm deep wells. The fill and vent holes are then anisotropically etched from the opposite side of the wafer. A 4000 A layer of thermal oxide (SiO,) is then grown on the etched surfaces of the wells. Finally, the chip is anodically bonded to 0.5 mm thick borosilicate glass to provide an optical window into the top of the PCR well. After the addition of sample, the chips are sealed with an acrylic-based pressure sensitive tape that is compatible with PCR chemistry (AR Care 7759, Adhesives
Research; Glen Rock, PA). Volumes of these silicon microstructures, which were manually filled and tested, ranged from 0.5 I_1to 9 I11 volumes [29] .
The polycarbonate plastic devices also used to run PCR were designed that have a 7 x 7 well array containing 49 wells per chip (Fig. 7B) . The design includes lmm x lmm x lmm wells (1 t_1volume) with a 250 micron sample distribution channel. The device includes a valve component for vacuum attachment and sample introduction. The plastic has no known material compatibility issues. Although the polycarbonate microstructure can be thermocycled more rapidly than ABI 7700 tubes, the thermal conductivity of plastic relative to silicon is a drawback for maximum cycle speed. The platic device can be assembled without adhesives or elevated temperatures using ultrasonic welding. Usingan inkjetroboticdeliverysystem, eachof the 49 reactionwells is loadedwithall or someof the PCRreagents. Thesereagents aredrieddownandthe deviceassembled. Thesampleto beanalyzed is loaded intothe valveandwhenthe vacuumsealis brokenthe chambers fillequallywith1 _1of thesample.
This systemof preloadinganddesiccating the reactants,and analyzing the PCR products in the cassetteaddresses two majorissuesthatwill be critical to any PCR-based monitor.First,reagentstorageand deliveryareaccomplished; the driedreagents arestable until dissolvedby the additionof the sample. T he preloading e liminates the need to develop sophisticatedmethodsof mixingseveral liquidsin a microchamber immediatelyprior to thermal cycling. Containment of the PCRproductsinsidethe cassette couldeliminatemostof the risk of subsequent PCRs yielding false positive results because they are contaminated witholdamplicons.
The capacity of the micro-PCRsystem to performrealtime sequencespecificdetectionof PCR productsin silicon-based microstructures (Fig7B) has beendemonstrated [30] . Inassaysthatwereoptimized to detectDNAsequences fromthe human13-globin gene and from bacteriophagelambda, equivalent PCR reaction yields, sensitivities,and specificitieswere observedfor the siliconmicrostructures usedwiththe micro-PCR system and for the larger volume polypropylene tubesusedin the ABI7700.The microPCRsystemdetecteda singlecopyof boththe i3-actin andlambdaPCRtargets [30] .
Therearesignificant differences betweenmicro andnormal devices. Theabilityto performsmallPCRin highlyconductivematerialssuch as siliconoffersthe potential of rapid cycling, improved temperature uniformity,lower reagentcosts, and minimalsample requirements. Analysisonthe microscaleis beingdone in volumesas smallas 0.5pl; whereasnormal volumes forPCRusingtheABI7700are25-1001_1. Miniaturization of the PCR reactioncontainerresultsin significantly highersurface-to-volume ratiosin the microstructures than in largervolumereactiontubes.This higherratio maybethe reasonthatmicro-PCRs requirethe addition of small amountsof carrier protein (bovine serum albumin0.05%w/v) or higher Taq DNA polymerase concentrations to match tube chemistry reaction performance [30] .
The inclusion of carrier protein is probably needed to limit binding of the DNA polymerase to the microstructure wall surfaces. Miniaturization of PCR structures lowers the cost and the amount of wastes generated considerably because smaller amounts of reagents are being used. Importantly these microstructures can be cycled at extremely fast rates. The temperature ramp rates are increased four fold to 4°C /sec and the cycle times reduced. For the 13-actin assay this results in an overall cycle time of 32.5 seconds in the chip format versus 2 minutes, 35 seconds in tubes (a five fold reduction). The 2-cycle PCR times for the microstructure were 95°-5 seconds; 60°-10 seconds. No significant difference in PCR yield was seen between normal and fast cycle times[30].
SUMMARY
5' Nuclease assay PCR chemistry offers the possibility of monitoring the number of microorganisms in any kind of sample. It has two major improvements over gel-based post-PCR analytic methods, and both of these advances are essential to meeting NASA's needs for a microbial monitor for the ISS.
• Although pre-PCR sample preparation and the PCR itself can require several hours to complete, the 5' nuclease assay greatly accelerates the total process of PCR-based microbial detection and quantitation relative to standard PCR diagnostic techniques This increase in speed is possible because detection of PCR products is done in real time and integrated with the thermal cycling.
•
The 5' nuclease assay PCR is an inherently quantitative technique. Within a range of template concentrations, the assay's fluorescent signal will be proportional to the amount of template present. Thus the number microorganisms in a sample can be quantitated. Any method that measures the amount of PCR amplicon generated only after the reaction is complete will be subject to errors resulting from the non-linearity of amplicon generation throughout the thermocycling. Alternatively,we are consideringan instrument designthatwouldsequentially analyzefora different kind of microorganismevery 30 minutes,or 48 different assays every 24 hours This proposed device would employ flow injection analysis technology to eliminate the generation of disposable reactionvessels. PCRswouldbesequentially done in a capillary tube that would replace the microdevicesused in the current version of the micro-PCR instrument. Theonlywasteproduct from such a detectionsystemwould be the microliter amountsof PCR product.Minimizationof waste productionon the ISS will be essentialon long missions. 5' nucleaseassaysfor the Salmonella,and the waterborne parasites, GiardiaandCryptosporidium reliablycan detectas few as 10 organisms. This level of sensitivityis at the theoreticallimit of detectionof the technologydue to the statistical uncertainty aboutthe actualcontentof any sample dilutedtothe levelofhavinglessthan10copiesofa solute.
As we continueto develop5' nucleaseassay PCRassaysfor an ISSmicrobial monitor, wemustalso address thesesignificant issues.
• An effective method must be selected to eliminate all contaminating bacterial DNA from PCR enzymes. We will test both DNase I and psoralen treatment of the enzymes to determine if either of these methods will work in our application as they have in others. This is not a major problem, and once solved our universal bacteria and coliform bacteria assays should function as well as the Salmonella and polio virus assays.
• Sample preparation is a major concern. Methods that are now routinely performed in diagnostic PCR labs may not be suitable for 5' nuclease PCRor in a fully automated microbial monitor designed for ISS use. For instance, a protocol in wide use for the preparation of clinical and environmental samples for diagnostic PCR uses a ion-chelating reagent, Chelex (Bio-Rad), to remove PCR inhibitors. This method may not be adaptable to 5' nuclease assay PCR. After processing, any residual Chelex remaining in a sample can inhibit the 5' nuclease assay reaction.
Comparison of the Chelex sample preparation methods with the EnviroAmp TM method and the phenol/chloroform extraction-ethanol precipitation method suggests it may be necessary to employ an extraction procedure that uses either or both proteolytic enzymes and organic extraction of potential inhibitors (data not shown). We are beginning work with a microbial detection group at Pacific Northwest National Labs to address that issue as well as the problem of concentrating any microorganisms present in water to a level that they can be robustly detected by a PCR based monitor (_>100copies of the PCR target in a 5 ILl sample).
Our monitor will need to distinguish viable from nonviable bacteria, parasites, and fungi. PCR detection looking for DNA targets will not select for viable cells; however we are beginning a collaboration with a group from the United Kingdom who has developed 5' nuclease assay PCRs for a specific bacterial mRNAs; bacterial mRNA is an ephemeral species. Our colleagues have found it has a half life of 10 seconds in E. coil We believe the current set of studies assaying for microbial DNA will give us the knowledge necessary to develop assays for viable cells by looking for specific mRNAs using the RT-PCR technology we used to amplify polio virus RNA. 
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